Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
Identifieur interne : 000602 ( Main/Exploration ); précédent : 000601; suivant : 000603Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
Auteurs : Bruno Mégarbane [France] ; Jean-Michel Scherrmann [France]Source :
- The Journal of antimicrobial chemotherapy [ 1460-2091 ] ; 2021.
Descripteurs français
- KwdFr :
- MESH :
- épidémiologie : Infections à coronavirus.
- Humains, Hydroxychloroquine, Pandémies, Pneumopathie virale.
English descriptors
- KwdEn :
- MESH :
- chemical : Hydroxychloroquine.
- epidemiology : Coronavirus Infections.
- COVID-19, Humans, Pandemics, Pneumonia, Viral, SARS-CoV-2.
DOI: 10.1093/jac/dkaa327
PubMed: 32766679
PubMed Central: PMC7454555
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.</title><author><name sortKey="Megarbane, Bruno" sort="Megarbane, Bruno" uniqKey="Megarbane B" first="Bruno" last="Mégarbane">Bruno Mégarbane</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology APHP, University of Paris, INSERM UMRS-1144, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology APHP, University of Paris, INSERM UMRS-1144, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Scherrmann, Jean Michel" sort="Scherrmann, Jean Michel" uniqKey="Scherrmann J" first="Jean-Michel" last="Scherrmann">Jean-Michel Scherrmann</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Pharmacy, University of Paris, INSERM UMRS-1144, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Faculty of Pharmacy, University of Paris, INSERM UMRS-1144, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2021">2021</date><idno type="RBID">pubmed:32766679</idno><idno type="pmid">32766679</idno><idno type="doi">10.1093/jac/dkaa327</idno><idno type="pmc">PMC7454555</idno><idno type="wicri:Area/Main/Corpus">000F49</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000F49</idno><idno type="wicri:Area/Main/Curation">000F49</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000F49</idno><idno type="wicri:Area/Main/Exploration">000F49</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.</title><author><name sortKey="Megarbane, Bruno" sort="Megarbane, Bruno" uniqKey="Megarbane B" first="Bruno" last="Mégarbane">Bruno Mégarbane</name><affiliation wicri:level="3"><nlm:affiliation>Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology APHP, University of Paris, INSERM UMRS-1144, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology APHP, University of Paris, INSERM UMRS-1144, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Scherrmann, Jean Michel" sort="Scherrmann, Jean Michel" uniqKey="Scherrmann J" first="Jean-Michel" last="Scherrmann">Jean-Michel Scherrmann</name><affiliation wicri:level="3"><nlm:affiliation>Faculty of Pharmacy, University of Paris, INSERM UMRS-1144, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Faculty of Pharmacy, University of Paris, INSERM UMRS-1144, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j">The Journal of antimicrobial chemotherapy</title><idno type="eISSN">1460-2091</idno><imprint><date when="2021" type="published">2021</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>COVID-19 (MeSH)</term><term>Coronavirus Infections (epidemiology)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (MeSH)</term><term>SARS-CoV-2 (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Humains (MeSH)</term><term>Hydroxychloroquine (MeSH)</term><term>Infections à coronavirus (épidémiologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" xml:lang="en"><term>COVID-19</term><term>Humans</term><term>Pandemics</term><term>Pneumonia, Viral</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Hydroxychloroquine</term><term>Pandémies</term><term>Pneumopathie virale</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32766679</PMID><DateCompleted><Year>2020</Year><Month>12</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2091</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>01</Month><Day>01</Day></PubDate></JournalIssue><Title>The Journal of antimicrobial chemotherapy</Title><ISOAbbreviation>J Antimicrob Chemother</ISOAbbreviation></Journal><ArticleTitle>Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.</ArticleTitle><Pagination><MedlinePgn>276-277</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkaa327</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mégarbane</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology APHP, University of Paris, INSERM UMRS-1144, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherrmann</LastName><ForeName>Jean-Michel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, University of Paris, INSERM UMRS-1144, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Antimicrob Chemother</MedlineTA><NlmUniqueID>7513617</NlmUniqueID><ISSNLinking>0305-7453</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>J Antimicrob Chemother. 2020 Sep 1;75(9):2376-2380</RefSource><PMID Version="1">32473020</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Antimicrob Chemother. 2021 Jan 1;76(1):277-279</RefSource><PMID Version="1">33089306</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32766679</ArticleId><ArticleId IdType="pii">5882112</ArticleId><ArticleId IdType="doi">10.1093/jac/dkaa327</ArticleId><ArticleId IdType="pmc">PMC7454555</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMJ. 2020 May 14;369:m1849</Citation><ArticleIdList><ArticleId IdType="pubmed">32409561</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2020 Oct;108(4):775-790</Citation><ArticleIdList><ArticleId IdType="pubmed">32438446</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation><ArticleIdList><ArticleId IdType="pubmed">32150618</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2020 Sep;46(9):1772-1773</Citation><ArticleIdList><ArticleId IdType="pubmed">32514594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Discov. 2020 Mar 18;6:16</Citation><ArticleIdList><ArticleId IdType="pubmed">32194981</ArticleId></ArticleIdList></Reference><Reference><Citation>J Pharmacokinet Pharmacodyn. 2020 Jun;47(3):187-188</Citation><ArticleIdList><ArticleId IdType="pubmed">32405664</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Pharmacol Ther. 2020 Aug;108(2):253-263</Citation><ArticleIdList><ArticleId IdType="pubmed">32285930</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Transl Sci. 2020 Jul;13(4):642-645</Citation><ArticleIdList><ArticleId IdType="pubmed">32268005</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2020 May 21;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32435791</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 2020 Sep 1;75(9):2376-2380</Citation><ArticleIdList><ArticleId IdType="pubmed">32473020</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Megarbane, Bruno" sort="Megarbane, Bruno" uniqKey="Megarbane B" first="Bruno" last="Mégarbane">Bruno Mégarbane</name></region><name sortKey="Scherrmann, Jean Michel" sort="Scherrmann, Jean Michel" uniqKey="Scherrmann J" first="Jean-Michel" last="Scherrmann">Jean-Michel Scherrmann</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000602 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000602 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32766679
|texte= Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32766679" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |